Clinical Trials Browser

NIH × Melanoma × Azacitidine × Clear all

NCT00217542 2013-05-03

Azacitidine and Recombinant Interferon Alfa-2b in Treating Patients With Stage III or Stage IV Melanoma or Stage IV Kidney Cancer That Cannot Be Removed By Surgery

Phase 1 Completed

DermatologicGenitourinary

Carcinoma, Renal Cell, Melanoma